By Apeksha Damania
Apeksha Damania and Bill Woywod examine how recent medical imaging advances in oncology are bringing about new areas of precision medicine, and preview its full potential. They highlight how the use of AI-driven medical imaging and AI-integrated nanotechnology offer new opportunities for the development of novel strategies in terms of prevention, diagnosis, and treatment of various diseases.
Read the full byline in Cell&Gene.
Guidehouse is a global advisory, technology, and managed services firm delivering value to commercial businesses and federal, state, and local governments. Serving industries focused on communities, energy, infrastructure, healthcare, financial services, defense, and national security, Guidehouse positions clients for AI-led innovation, efficiency, and resilience.